Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.0 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
39 priced months, Jun 2022 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
75.8% now, 76.8% in Sep 2025 · highest 82.6%, lowest 75.8%
Companies held
20 now, 20 in Sep 2025 · largest single holding 17.0% of equity
How it trades: no clear lean toward recent winners or losers (score -0.01 over 25 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 20 shared100.0%
- DSP Nifty Healthcare Index FundDSP · 20 shared100.0%
- DSP Nifty Healthcare ETFDSP · 20 shared100.0%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 20 shared99.9%
- EODWHFEdelweiss · 18 shared91.8%
- Nippon India Nifty Pharma ETFNippon India · 16 shared81.1%
- ICICI Prudential Nifty Pharma Index FundICICI Prudential · 16 shared81.1%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared79.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
Largest reductions
- 01 Biocon Limited-4.5% -662
- 02 Sun Pharmaceutical Industries Limited-2.2% -483
- 03 Max Healthcare Institute Limited-2.2% -340
- 04 Dr. Reddy's Laboratories Limited-2.1% -272
- 05 Cipla Limited-2.2% -255
- 06 Fortis Healthcare Limited-2.2% -239
- 07 Laurus Labs Limited-2.1% -169
- 08 Zydus Lifesciences Limited-3.1% -162
- 09 Aurobindo Pharma Limited-2.3% -135
- 10 Lupin Limited-2.2% -109
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 17.00% | 3.92 Cr | 21,585 | by Jun 2022 (39 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 10.44% | 2.41 Cr | 2,591 | by Jun 2022 (39 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 7.43% | 1.71 Cr | 2,098 | by Jun 2022 (39 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 6.82% | 1.57 Cr | 7,940 | by Jun 2022 (39 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.70% | 1.54 Cr | 11,472 | by Jun 2022 (39 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 6.65% | 1.53 Cr | 12,432 | by Jun 2022 (39 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 6.24% | 1.44 Cr | 3,000 | by Jun 2022 (39 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 6.12% | 1.41 Cr | 15,171 | Oct 2023 (30 mo) |
| Lupin Limited | Healthcare | Mid Cap | 4.36% | 1.01 Cr | 4,952 | by Jun 2022 (39 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.09% | 0.94 Cr | 5,634 | by Jun 2022 (39 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 3.55% | 0.82 Cr | 10,622 | Mar 2025 (19 mo) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 3.11% | 0.72 Cr | 3,069 | by Jun 2022 (39 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 2.75% | 0.63 Cr | 1,229 | by Jun 2022 (39 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.55% | 0.59 Cr | 5,052 | by Jun 2022 (39 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.51% | 0.58 Cr | 2,310 | Mar 2025 (19 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.37% | 0.55 Cr | 2,832 | by Jun 2022 (39 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 2.28% | 0.53 Cr | 14,207 | by Jun 2022 (39 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.04% | 0.47 Cr | 1,625 | Sep 2026 (1 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 1.76% | 0.41 Cr | 5,440 | Sep 2026 (1 mo) |
| Abbott India Limited | Healthcare | Mid Cap | 1.25% | 0.29 Cr | 106 | by Jun 2022 (39 mo+) |
Half of its current holdings have been held for 39 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Piramal Pharma Limited | Sep 2026 | ▼ Complete exit | -12,963 |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ New position | +5,440 |
| Syngene International Limited | Sep 2026 | ▼ Complete exit | -3,962 |
| Gland Pharma Limited | Sep 2026 | ▲ New position | +1,625 |
| Biocon Limited | Sep 2026 | ▼ Reducing | -662 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▼ Reducing | -483 |
| Max Healthcare Institute Limited | Sep 2026 | ▼ Reducing | -340 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▼ Reducing | -272 |
| Cipla Limited | Sep 2026 | ▼ Reducing | -255 |
| Fortis Healthcare Limited | Sep 2026 | ▼ Reducing | -239 |
| Laurus Labs Limited | Sep 2026 | ▼ Reducing | -169 |
| Zydus Lifesciences Limited | Sep 2026 | ▼ Reducing | -162 |
| Aurobindo Pharma Limited | Sep 2026 | ▼ Reducing | -135 |
| Lupin Limited | Sep 2026 | ▼ Reducing | -109 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -69 |
| IPCA Laboratories Limited | Sep 2026 | ▼ Reducing | -63 |
| Divi's Laboratories Limited | Sep 2026 | ▼ Reducing | -58 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -57 |
| Mankind Pharma Limited | Sep 2026 | ▼ Reducing | -50 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▼ Reducing | -47 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +9 |
| Abbott India Limited | Sep 2026 | ▼ Reducing | -3 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▼ Reducing | -759 |
| Max Healthcare Institute Limited | Aug 2026 | ▼ Reducing | -533 |
| Biocon Limited | Aug 2026 | ▼ Reducing | -511 |
| Piramal Pharma Limited | Aug 2026 | ▼ Reducing | -445 |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▼ Reducing | -437 |
| Cipla Limited | Aug 2026 | ▼ Reducing | -403 |
| Fortis Healthcare Limited | Aug 2026 | ▼ Reducing | -373 |
| Laurus Labs Limited | Aug 2026 | ▼ Reducing | -279 |
| Aurobindo Pharma Limited | Aug 2026 | ▼ Reducing | -198 |
| Zydus Lifesciences Limited | Aug 2026 | ▼ Reducing | -179 |
| Lupin Limited | Aug 2026 | ▼ Reducing | -174 |
| Syngene International Limited | Aug 2026 | ▼ Reducing | -136 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -108 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -105 |
| IPCA Laboratories Limited | Aug 2026 | ▼ Reducing | -99 |
| Divi's Laboratories Limited | Aug 2026 | ▼ Reducing | -91 |
| Mankind Pharma Limited | Aug 2026 | ▼ Reducing | -81 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▼ Reducing | -73 |
| Alkem Laboratories Limited | Aug 2026 | ▼ Reducing | -41 |
| Abbott India Limited | Aug 2026 | ▼ Reducing | -3 |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +861 |
| Sun Pharmaceutical Industries Limited | Jul 2026 | ▼ Reducing | -395 |
| Max Healthcare Institute Limited | Jul 2026 | ▼ Reducing | -277 |
| Biocon Limited | Jul 2026 | ▼ Reducing | -266 |
| Piramal Pharma Limited | Jul 2026 | ▼ Reducing | -232 |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▼ Reducing | -227 |
| Cipla Limited | Jul 2026 | ▼ Reducing | -210 |
| Fortis Healthcare Limited | Jul 2026 | ▼ Reducing | -194 |
| Laurus Labs Limited | Jul 2026 | ▼ Reducing | -145 |
| Aurobindo Pharma Limited | Jul 2026 | ▼ Reducing | -103 |
| Zydus Lifesciences Limited | Jul 2026 | ▼ Reducing | -94 |
| Lupin Limited | Jul 2026 | ▼ Reducing | -91 |
| Syngene International Limited | Jul 2026 | ▼ Reducing | -71 |
| Glenmark Pharmaceuticals Limited | Jul 2026 | ▼ Reducing | -56 |
| IPCA Laboratories Limited | Jul 2026 | ▼ Reducing | -52 |
| Divi's Laboratories Limited | Jul 2026 | ▼ Reducing | -47 |
| Mankind Pharma Limited | Jul 2026 | ▼ Reducing | -42 |
| Apollo Hospitals Enterprise Limited | Jul 2026 | ▼ Reducing | -39 |
| Alkem Laboratories Limited | Jul 2026 | ▼ Reducing | -22 |
| Abbott India Limited | Jul 2026 | ▼ Reducing | -2 |
| Aurobindo Pharma Limited | Jun 2026 | ▼ Reducing | -61 |
| Piramal Pharma Limited | Jun 2026 | ▲ Increasing | +49 |
| Biocon Limited | Jun 2026 | ▼ Reducing | -8 |
| Torrent Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +7 |
| Syngene International Limited | Jun 2026 | ▲ Increasing | +7 |
| Lupin Limited | Jun 2026 | ▲ Increasing | +7 |
| Dr. Reddy's Laboratories Limited | Jun 2026 | ▲ Increasing | +3 |
| Mankind Pharma Limited | Jun 2026 | ▲ Increasing | +2 |
| Fortis Healthcare Limited | Jun 2026 | ▼ Reducing | -2 |
| Sun Pharmaceutical Industries Limited | May 2026 | ▲ Increasing | +1,596 |
| Max Healthcare Institute Limited | May 2026 | ▲ Increasing | +1,122 |
| Biocon Limited | May 2026 | ▲ Increasing | +1,076 |
| Piramal Pharma Limited | May 2026 | ▲ Increasing | +934 |
| Dr. Reddy's Laboratories Limited | May 2026 | ▲ Increasing | +918 |
| Cipla Limited | May 2026 | ▲ Increasing | +848 |
| Fortis Healthcare Limited | May 2026 | ▲ Increasing | +786 |
| Laurus Labs Limited | May 2026 | ▲ Increasing | +586 |
| Aurobindo Pharma Limited | May 2026 | ▲ Increasing | +422 |
| Zydus Lifesciences Limited | May 2026 | ▲ Increasing | +378 |
| Lupin Limited | May 2026 | ▲ Increasing | +366 |
| Syngene International Limited | May 2026 | ▲ Increasing | +286 |
| Glenmark Pharmaceuticals Limited | May 2026 | ▲ Increasing | +228 |
| IPCA Laboratories Limited | May 2026 | ▲ Increasing | +210 |
| Divi's Laboratories Limited | May 2026 | ▲ Increasing | +192 |
| Mankind Pharma Limited | May 2026 | ▲ Increasing | +170 |
| Torrent Pharmaceuticals Limited | May 2026 | ▲ Increasing | +158 |
| Apollo Hospitals Enterprise Limited | May 2026 | ▲ Increasing | +156 |
| Alkem Laboratories Limited | May 2026 | ▲ Increasing | +88 |
| Abbott India Limited | May 2026 | ▲ Increasing | +8 |
| Sun Pharmaceutical Industries Limited | Apr 2026 | ▼ Reducing | -819 |
| Max Healthcare Institute Limited | Apr 2026 | ▼ Reducing | -568 |
| Biocon Limited | Apr 2026 | ▼ Reducing | -497 |
| Piramal Pharma Limited | Apr 2026 | ▼ Reducing | -480 |
| Dr. Reddy's Laboratories Limited | Apr 2026 | ▼ Reducing | -470 |
| Cipla Limited | Apr 2026 | ▼ Reducing | -422 |
| Fortis Healthcare Limited | Apr 2026 | ▼ Reducing | -390 |
| Laurus Labs Limited | Apr 2026 | ▼ Reducing | -280 |
| Aurobindo Pharma Limited | Apr 2026 | ▼ Reducing | -213 |
Changes compare consecutive month-end disclosures for this portfolio only.